Human Milk Oligosaccharides (HMOs) in reducing the risk of Necrotising Enterocolitis: A forward-looking Journey from preclinical to human Cohort Studies

Posted: Jun 24, 2018

In this publication, Lars Bode has reviewed the role of HMOs in reducing the risk of necrotising enterocolitis.

Download slides

Bode-2018-ppt

Recommended Content

Please log in to your profile so we can show recommended content.

Sign up